Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.

The surface modification of nanoparticles (NPs) can enhance the intracellular delivery of drugs, proteins, and genetic agents. Here we studied the effect of different surface ligands, including cell penetrating peptides (CPPs), on the cell binding and internalization of poly(lactic-co-glycolic) (PLGA) NPs. Relative to unmodified NPs, we observed that surface-modified NPs greatly enhanced cell internalization. Using one CPP, MPG (unabbreviated notation), that achieved the highest degree of internalization at both low and high surface modification densities, we evaluated the effect of two different NP surface chemistries on cell internalization. After 2h, avidin-MPG NPs enhanced cellular internalization by 5 to 26-fold relative to DSPE-MPG NP formulations. Yet, despite a 5-fold increase in MPG density on DSPE compared to Avidin NPs, both formulations resulted in similar internalization levels (48 and 64-fold, respectively) after 24h. Regardless of surface modification, all NPs were internalized through an energy-dependent, clathrin-mediated process, and became dispersed throughout the cell. Overall both Avidin- and DSPE-CPP modified NPs significantly increased internalization and offer promising delivery options for applications in which internalization presents challenges to efficacious delivery.

[1]  S. Reissmann,et al.  Transduction of peptides and proteins into live cells by cell penetrating peptides , 2011, Journal of cellular biochemistry.

[2]  Simon Benita,et al.  Targeting of nanoparticles to the clathrin-mediated endocytic pathway. , 2007, Biochemical and biophysical research communications.

[3]  Christopher J. Cheng,et al.  Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. , 2011, Biomaterials.

[4]  Kirsten Sandvig,et al.  Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies , 2011 .

[5]  Ü. Langel,et al.  Delivery of short interfering RNA using endosomolytic cell‐penetrating peptides , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  M. Garnett,et al.  Ligand density and clustering effects on endocytosis of folate modified nanoparticles , 2012 .

[8]  Yong Ren,et al.  Recent advances in nanoparticle-mediated siRNA delivery. , 2014, Annual review of biomedical engineering.

[9]  J. Swanson,et al.  A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages , 1996, The Journal of cell biology.

[10]  J. Gariépy,et al.  Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells. , 2006, Biochemistry.

[11]  W. Mark Saltzman,et al.  A holistic approach to targeting disease with polymeric nanoparticles , 2015, Nature Reviews Drug Discovery.

[12]  Ting-Yi Wang,et al.  Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges , 2012, Pharmaceuticals.

[13]  M. Pooga,et al.  Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  T. Ohtsuki,et al.  Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. , 2009, Advanced drug delivery reviews.

[15]  Parag Aggarwal,et al.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.

[16]  F Atyabi,et al.  Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents , 2011, International journal of nanomedicine.

[17]  Tanapon Phenrat,et al.  Nanoparticle aggregation: challenges to understanding transport and reactivity in the environment. , 2010, Journal of environmental quality.

[18]  S. Ostad,et al.  Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel , 2013, DARU Journal of Pharmaceutical Sciences.

[19]  R. Prud’homme,et al.  Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[20]  G. Divita,et al.  Direct Translocation as Major Cellular Uptake for CADY Self-Assembling Peptide-Based Nanoparticles , 2011, PloS one.

[21]  C. Frank,et al.  Adsorption of lipid-functionalized poly(ethylene glycol) to gold surfaces as a cushion for polymer-supported lipid bilayers. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[22]  Xinguo Jiang,et al.  Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery. , 2012, International journal of pharmaceutics.

[23]  Victoria A. Higman,et al.  Regulation of endosomal membrane traffic by a Gadkin/AP-1/kinesin KIF5 complex , 2009, Proceedings of the National Academy of Sciences.

[24]  T. Rana,et al.  Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. , 2004, Chemistry & biology.

[25]  T. Kissel,et al.  Characterization of a homologous series of D,L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro. , 2003, Biomaterials.

[26]  N. Shafiq,et al.  Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead. , 2012, Critical reviews in therapeutic drug carrier systems.

[27]  V. Préat,et al.  PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[28]  W. Saltzman,et al.  Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[30]  K. Landfester,et al.  Competitive cellular uptake of nanoparticles made from polystyrene, poly(methyl methacrylate), and polylactide. , 2012, Macromolecular bioscience.

[31]  W. Saltzman,et al.  Bioengineering Approaches to Controlled Protein Delivery , 2008, Pediatric Research.

[32]  Christopher J. Cheng,et al.  Nanomedicine: Downsizing tumour therapeutics. , 2012, Nature nanotechnology.

[33]  Hirenkumar K. Makadia,et al.  Poly Lactic-co-Glycolic Acid ( PLGA ) as Biodegradable Controlled Drug Delivery Carrier , 2011 .

[34]  Qi Shen,et al.  Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  J. Swanson,et al.  Phosphoinositide-3-kinase-independent contractile activities associated with Fcγ-receptor-mediated phagocytosis and macropinocytosis in macrophages , 2003, Journal of Cell Science.

[36]  H. Hinrichsen,et al.  Agglomeration of charged nanopowders in suspensions , 2002, cond-mat/0210187.

[37]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[38]  Ülo Langel,et al.  Cell-penetrating peptides for the delivery of nucleic acids , 2012, Expert opinion on drug delivery.

[39]  Yen Cu,et al.  In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[40]  G. Wei,et al.  Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin. , 2013, International journal of pharmaceutics.

[41]  Shan Wang,et al.  Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. , 2011, Blood.

[42]  Rainer Fischer,et al.  A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides , 2007, Traffic.

[43]  G. Shavi,et al.  PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation , 2012, Bulletin of Materials Science.

[44]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[45]  Ross R. Muth,et al.  Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1 , 1979 .

[46]  Vladimir P Torchilin,et al.  Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. , 2008, Biopolymers.

[47]  M. Götte,et al.  Biglycan is internalized via a chlorpromazine-sensitive route. , 2004, Cellular & molecular biology letters.

[48]  Steven F Dowdy,et al.  Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. , 2007, Advanced drug delivery reviews.

[49]  Christopher J. Cheng,et al.  MicroRNA silencing for cancer therapy targeted to the tumor microenvironment , 2014, Nature.

[50]  W. Saltzman,et al.  Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors. , 2012, Biomaterials.

[51]  Haliza Katas,et al.  Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method , 2008, Journal of microencapsulation.

[52]  M. Morris,et al.  Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. , 2003, Nucleic acids research.

[53]  T. Kissel,et al.  Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[54]  Dan Gilead,et al.  Degradable polymers : principles and applications , 1995 .

[55]  Simon Benita,et al.  Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. , 2008, Biomacromolecules.

[56]  W. Mark Saltzman,et al.  Therapeutic siRNA: Principles, Challenges, and Strategies , 2012, The Yale journal of biology and medicine.

[57]  Ralph Weissleder,et al.  Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. , 2010, Bioconjugate chemistry.

[58]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[59]  D. Malide,et al.  Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2005, Journal of Biological Chemistry.

[60]  Indu Bala,et al.  PLGA nanoparticles in drug delivery: the state of the art. , 2004, Critical reviews in therapeutic drug carrier systems.

[61]  Jill M. Steinbach.  Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs , 2014, Cellular and Molecular Life Sciences.

[62]  Iseult Lynch,et al.  Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. , 2011, Small.

[63]  Daan Frenkel,et al.  Receptor-mediated endocytosis of nanoparticles of various shapes. , 2011, Nano letters.

[64]  Christopher J. Cheng,et al.  Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[65]  R. Langer,et al.  Progress in siRNA delivery using multifunctional nanoparticles. , 2010, Methods in molecular biology.

[66]  A. Ivanov,et al.  Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? , 2008, Methods in molecular biology.

[67]  J. Gong,et al.  Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[68]  Francesco Stellacci,et al.  Effect of surface properties on nanoparticle-cell interactions. , 2010, Small.

[69]  M. Morris,et al.  Cell‐penetrating peptides: from molecular mechanisms to therapeutics , 2008, Biology of the cell.

[70]  Claus-Michael Lehr,et al.  Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[71]  N. Wu,et al.  Experimental and statistical analysis of surface charge, aggregation and adsorption behaviors of surface-functionalized titanium dioxide nanoparticles in aquatic system , 2012, Journal of Nanoparticle Research.

[72]  Kurt Ballmer-Hofer,et al.  Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.

[73]  W. Saltzman,et al.  Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[74]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[75]  Kinam Park,et al.  PLGA-PEG Block Copolymers for Drug Formulations By : , 2018 .

[76]  Jason Park,et al.  Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[77]  Steven F Dowdy,et al.  Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. , 2008, Advanced drug delivery reviews.

[78]  Tae Gwan Park,et al.  Degradation of poly(d,l-lactic acid) microspheres: effect of molecular weight , 1994 .

[79]  Yen Cu,et al.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus. , 2009, Molecular pharmaceutics.

[80]  N. M. Zaki,et al.  Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting , 2010, Expert opinion on drug delivery.

[81]  K. Uğurbil,et al.  Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding. , 2009, Bioconjugate chemistry.

[82]  K. Dawson,et al.  Effects of Transport Inhibitors on the Cellular Uptake of Carboxylated Polystyrene Nanoparticles in Different Cell Lines , 2011, PloS one.

[83]  I. Khalil,et al.  Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery , 2006, Pharmacological Reviews.

[84]  M. Morris,et al.  Interactions of amphipathic CPPs with model membranes. , 2006, Biochimica et biophysica acta.

[85]  N. Škalko-Basnet.  Biologics: the role of delivery systems in improved therapy , 2014, Biologics : targets & therapy.

[86]  C. C. Harness,et al.  Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. , 2005, Biomaterials.

[87]  R. Weiss,et al.  Surface-Modified Nanoparticles Enhance Transurothelial Penetration and Delivery of Survivin siRNA in Treating Bladder Cancer , 2013, Molecular Cancer Therapeutics.

[88]  K. Avgoustakis,et al.  Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. , 2004, Current drug delivery.

[89]  Astrid Gräslund,et al.  Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.

[90]  J. Au,et al.  Delivery of siRNA Therapeutics: Barriers and Carriers , 2010, The AAPS Journal.

[91]  J. Weidner.  Drug delivery. , 2001, Drug discovery today.

[92]  Dan Li,et al.  Shape and aggregation control of nanoparticles: not shaken, not stirred. , 2006, Journal of the American Chemical Society.

[93]  W. Mark Saltzman,et al.  Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA , 2009, Nature materials.

[94]  V. H. Lee,et al.  Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. , 2003, Molecular vision.

[95]  Weihong Tan,et al.  Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[96]  Lisa Brannon-Peppas,et al.  Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery , 1995 .

[97]  S. Dhar,et al.  Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis , 2013, Proceedings of the National Academy of Sciences.

[98]  Francesco Stellacci,et al.  Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. , 2008, Nature materials.

[99]  P. Fong,et al.  PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[100]  Vladimir P Torchilin,et al.  Cell-penetrating peptides: breaking through to the other side. , 2012, Trends in molecular medicine.